Should I take iron and zinc at the same time?

Last reviewed 29 April 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

Iron and zinc do interact at the level of intestinal absorption. The interaction is dose-ratio-dependent and largely confined to fasting-state pharmacological supplement doses. Rossander-Hultén 1991 showed that a 5:1 zinc-to-iron ratio in aqueous solution reduced iron absorption by 56%, but the same combination in a meal showed no inhibition. Olivares 2012 demonstrated 30-60 minute spacing eliminates the acute inhibition. For pharmacological doses, separation by 1-2 hours is sensible; for multivitamin-level doses with food, clinically meaningful interaction is unlikely.

How it works

What is clinically observable: dose-ratio-dependent acute inhibition in fasting conditions that disappears with food. The dietary matrix appears to provide enough buffering and binding ligands (proteins, fibres, organic acids) that the direct mineral-mineral competition observed in aqueous solutions is no longer seen. This is consistent with the broader pattern (Hurrell 2010 review) that single-meal isotope studies overstate the effect of dietary inhibitors of mineral absorption compared with whole-diet studies.

Effective dose

Multivitamin-level zinc (8-15 mg) combined with multivitamin-level iron (8-18 mg) sits at the lower end of the ratio threshold. The practical concern is more relevant when a patient is being actively repleted from iron deficiency at a 30-60 mg/day elemental iron dose alongside a separate zinc supplement.

Timing

Practical schedule for supplemental doses of both: iron mid-morning or with lunch; zinc with a different meal or before bed. The dose-ratio principle plus the food-buffering principle together mean that timing concern is much smaller for multivitamin-level doses taken with food. Iron should also be spaced at least 4 hours from levothyroxine and at least 2 hours from supplement-dose calcium.

Safety profile

Iron status should not be self-managed based purely on supplement timing. If iron supplementation is not improving iron status as expected, the underlying cause of the deficiency, the dose and form of iron, and the broader supplement regimen all need professional review. Self-supplementation with iron without a confirmed deficiency diagnosis can be harmful, particularly in haemochromatosis or other iron-loading conditions.

Special populations

Children: WHO and UNICEF have explored combined iron-zinc fortification programmes; results have been mixed because of the interaction. Wieringa 2007 (J Nutr 137(2):466-471) SEAMTIZI multi-country trial showed combined iron and zinc supplementation improved iron and zinc status, but interactions reduced the efficacy of each. The BSG 2021 iron deficiency guideline emphasises considering parenteral iron when oral repletion is inadequate in malabsorption contexts.

Interactions

Iron supplementation programmes in pregnant and lactating women have been associated with measurable reductions in zinc bioavailability when both are co-administered. Manganese also inhibits iron absorption from both aqueous solution and meals (Rossander-Hultén 1991), behaving differently from zinc in that respect. The broader iron interaction set (calcium, polyphenols, levothyroxine) is documented in the iron repletion entry.

Interaction	Issue	Guidance	Citation
Iron and zinc	Bidirectional, dose-ratio dependent inhibition	Separate iron and zinc supplements by around 1-2 hours	NIH ODS — Iron Fact Sheet for Health Professionals
Iron and calcium	Calcium reduces non-haem iron absorption	Separate iron supplements from calcium-containing meals by around 2 hours	NIH ODS — Iron Fact Sheet for Health Professionals
Iron and manganese	Manganese reduces iron absorption	Separate iron from manganese-containing supplements by around 1-2 hours	NIH ODS — Iron Fact Sheet for Health Professionals

Guideline positions

Sandström 1985 (J Nutr 115(3):411-414) showed Fe:Zn ratios of 25:1 reduced zinc absorption from aqueous solution but not from a rice and meat sauce meal. Olivares 2007 (Biol Trace Elem Res 117:7-14) confirmed acute zinc-on-iron inhibition in fasting humans. Hurrell 2010 review provides the broader context that single-meal isotope studies overstate dietary-context effects.

Practical framework

Olivares 2012 showed that 30-60 minutes is sufficient to eliminate the acute inhibition; 1-2 hours is conservative practical advice. The food-buffering principle means dietary intake of iron and zinc at the same meal is rarely a problem. The strongest practical implication: when iron deficiency is being actively corrected, plan supplement timing to avoid stacking pharmacological doses of both minerals at the same time. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: the interaction is purely a competition for DMT1. The classical DMT1 hypothesis is partial; recent enterocyte work suggests non-DMT1 mechanisms also contribute, possibly via the ZIP14 transporter. The clinical observation (dose-ratio dependence, food-buffering) is more reliable than any single mechanistic explanation.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Pregnancy
Breastfeeding
Children
Inflammatory bowel disease
Adults over 65

Recent updates

29 April 2026 — v3.1 -> v4 retrofit. (1) bottom_line: 1450 chars to 78 words. (2) structured_sections from 9 keys (mechanism, directionality, food_versus_fasting, special_populations, v3_1_changes_from_v2, practical_application, limitations_and_cautions, absorption_level_evidence, dose_and_ratio_thresholds) into 10 canonical (mechanism, effective_dose, timing, safety_profile, special_populations, interactions, guideline_anchors, practical_framework, common_misconceptions, cross_references). v3_1_changes_from_v2 dropped. directionality folded into interactions. food_versus_fasting folded into mechanism + practical_framework. dose_and_ratio_thresholds folded into effective_dose. absorption_level_evidence folded into guideline_anchors. (3) Drafted dash-free. Bottom_line "(Am J Clin Nutr) — using paired-observation" parenthetical removed; instead the methodology is mentioned in guideline_anchors. (4) Disclaimer updated. (5) Replaced ">=30 mg" Unicode-friendly text in practical_framework capsule with "30 mg or higher" for cleaner rendering. (6) population_tags: 5; medication_interactions: 1 (levothyroxine); supplement_interactions: 3 (zinc, calcium, manganese).
28 April 2026 — PLS rewritten 1767->3700 chars. Removed surname-based study refs (Rossander-Hulten, Solomons, Olivares names removed in favour of country/year). Dose-ratio-dependence, food-vs-fasting, mechanism uncertainty, populations, evidence-base limits. No inline PMIDs.
26 April 2026 — Built v3.1 marketing layer from empty. v2 said "compete via the same transporters" and "potentially by 50%" — both partially correct but oversimplified. v3.1 anchors to: Rossander-Hultén 1991 (PMID 2058577 — 5:1 Zn:Fe in aqueous solution = 56% iron absorption reduction; same combination in hamburger meal = NO inhibition; key finding suggests different absorptive pathways for iron and zinc), Sandström 1985 (J Nutr 115(3):411-414 — Fe:Zn 25:1 reduced zinc absorption from solution but not from food), Olivares 2007 (Biol Trace Elem Res 117:7-14 — confirmed acute zinc-on-iron inhibition in fasting humans), Olivares 2012 (Biometals 25(4):657-664 — 30-60 min spacing eliminated inhibition), Solomons 1986 (2:1 ratio threshold), Hurrell 2010 (single-meal vs multimeal divergence). Mechanism updated: original DMT1 hypothesis softened to acknowledge non-DMT1 mechanisms (possibly ZIP14) per recent Caco-2 work. v3.1 emphasises dose-ratio dependence and food-vs-fasting distinction — both clinically important and missing from v2.

Sources

Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L 1991. Competitive inhibition of iron absorption by manganese and zinc in humans. American Journal of Clinical Nutrition. PMID: 2058577 · DOI: 10.1093/ajcn/54.1.152
Sandström B, Davidsson L, Cederblad Å, Lönnerdal B 1985. Oral iron, dietary ligands and zinc absorption. Journal of Nutrition. PMID: 3973750 · DOI: 10.1093/jn/115.3.411
Olivares M, Pizarro F, Ruz M 2007. Zinc inhibits nonheme iron bioavailability in humans. Biological Trace Element Research. PMID: 17873388 · DOI: 10.1007/BF02698079
Olivares M, Pizarro F, Ruz M, López de Romaña D 2012. Acute inhibition of iron bioavailability by zinc: studies in humans. Biometals. PMID: 22297381 · DOI: 10.1007/s10534-012-9524-z
Hurrell R, Egli I 2010. Iron bioavailability and dietary reference values. American Journal of Clinical Nutrition. PMID: 20200263 · DOI: 10.3945/ajcn.2010.28674f
Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM 2021. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. PMID: 34497146 · DOI: 10.1136/gutjnl-2021-325210
NIH Office of Dietary Supplements. NIH Office of Dietary Supplements — Iron Fact Sheet for Health Professionals. NIH Office of Dietary Supplements (US government).

Back to Iron overview